Pfizer and Moderna shares fell after reports said Trump officials plan to link Covid vaccines to child deaths at a key CDC ...

智通财经APP获悉，周五，辉瑞(PFE.US)与Moderna(MRNA.US)股价双双下挫，此前有报道称，特朗普政府卫生官员计划在下周向美国疾病控制与预防中心(CDC)下属的一个关键疫苗咨询委员会，提出新冠疫苗与25名儿童死亡案例相关的主张。外媒援 ...

Moderna shares were down 7.4% Friday—their lowest level since March 2020. The drop brought the drugmaker’s year-to-date slump ...

Shares of companies that make COVID-19 vaccines sank Friday, after a report raised fears that Trump administration health ...

该报告发布之际，美国卫生与公众服务部部长小肯尼迪正采取行动改变美国的疫苗政策。他已经放弃了对健康儿童和孕妇的新冠疫苗接种建议，并对批准新的针对该病毒的疫苗接种设定了新的限制。

钛媒体App ...

This drop brings the stock's year-to-date decline to almost 45%. A key question now is how MRNA's performance compares to ...

摘要：英国制药巨头 GSK 近日扩大了针对 Moderna 的 mRNA 专利诉讼范围，将后者新一代新冠疫苗 mNexspike 纳入其中。此次诉讼延续了双方围绕脂质 mRNA 疫苗配方技术的争端，GSK 主张其相关专利早于新冠疫情十余年便已存在，而 Moderna 的多款疫苗均涉嫌侵权。目前 Moderna 表示将积极应诉，这场纠纷使得本就错综复杂的 mRNA ...

Moderna is working with advanced technology to help transform the way medicines are created, but is that enough reason to ...

The Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines Spikevax ® and mNexspike ®. The updated mRNA vaccines target the LP.8.1 variant of ...

Moderna, Inc. (NASDAQ:MRNA) today announced that five abstracts on its investigational mRNA therapeutics have been accepted ...